Actinium Pharmaceuticals OverviewActinium Pharmaceuticals Other Income Expense Net
Other Income/Expense Net for ATNM.
Quarterly Other Income/Expense
$381000.00
↓ 45.57% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$2.04M
↓ 44.1% YoY
Trailing 12 months ending Mar 31, 2026